{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:27:55Z","timestamp":1790015275390,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004096","name":"Kyushu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K15717"],"award-info":[{"award-number":["JP23K15717"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K19623"],"award-info":[{"award-number":["JP24K19623"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.joca.2025.11.007","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:51:04Z","timestamp":1763693464000},"page":"105-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Imeglimin, a novel antidiabetic agent related to metformin, attenuates knee osteoarthritis development and progression through AMPK activation and NF-\u03baB signaling inhibition"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4279-890X","authenticated-orcid":false,"given":"Yuki","family":"Hyodo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3666-3952","authenticated-orcid":false,"given":"Yukio","family":"Akasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-6536","authenticated-orcid":false,"given":"Ichiro","family":"Kurakazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5530-0960","authenticated-orcid":false,"given":"Taisuke","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3357-1304","authenticated-orcid":false,"given":"Ryota","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6597-9744","authenticated-orcid":false,"given":"Takumi","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3829-4240","authenticated-orcid":false,"given":"Koki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2025.11.007_bib1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2025.11.007_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2025.11.007_bib3","doi-asserted-by":"crossref","first-page":"d1165","DOI":"10.1136\/bmj.d1165","article-title":"All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study","volume":"342","author":"N\u00fcesch","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2025.11.007_bib4","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S295224","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date","volume":"15","author":"Oo","year":"2021","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.joca.2025.11.007_bib5","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.joca.2016.07.017","article-title":"Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future","volume":"24","author":"Karsdal","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2025.11.007_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.joca.2025.11.007_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cell.2013.02.035","article-title":"Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism","volume":"153","author":"Cabreiro","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.joca.2025.11.007_bib8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.joca.2025.11.007_bib9","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.cell.2024.08.021","article-title":"Metformin decelerates aging clock in male monkeys","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.joca.2025.11.007_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.joca.2023.11.018","article-title":"Aging and the emerging role of cellular senescence in osteoarthritis","volume":"32","author":"Diekman","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2025.11.007_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/dom.12354","article-title":"Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls","volume":"16","author":"Bannister","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.joca.2025.11.007_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","article-title":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis","volume":"40","author":"Campbell","year":"2017","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.joca.2025.11.007_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41586-019-1365-2","article-title":"From discoveries in ageing research to therapeutics for healthy ageing","volume":"571","author":"Campisi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.joca.2025.11.007_bib14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.joca.2025.11.007_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2019-216713","article-title":"Metformin limits osteoarthritis development and progression through activation of AMPK signalling","volume":"79","author":"Li","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2025.11.007_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13075-020-2129-y","article-title":"Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior","volume":"22","author":"Li","year":"2020","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.joca.2025.11.007_bib17","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3389\/fphar.2020.01114","article-title":"Metformin mitigates cartilage degradation by activating AMPK\/SIRT1-mediated autophagy in a mouse osteoarthritis model","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.joca.2025.11.007_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.5582\/bst.2018.01263","article-title":"Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1\/Parkin-dependent mitophagy in primary chondrocytes","volume":"12","author":"Wang","year":"2019","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.joca.2025.11.007_bib19","first-page":"632","article-title":"Metformin protects chondrocytes against IL-1\u03b2 induced injury by regulation of the AMPK\/NF-\u03ba B signaling pathway","volume":"75","author":"Zhang","year":"2020","journal-title":"Pharmazie"},{"key":"10.1016\/j.joca.2025.11.007_bib20","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.3390\/ijms24065355","article-title":"Metformin attenuates the inflammatory response via the regulation of synovial M1 macrophage in osteoarthritis","volume":"24","author":"Zheng","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.joca.2025.11.007_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.3646","article-title":"Development of osteoarthritis in adults with type 2 diabetes treated with metformin vs a sulfonylurea","volume":"6","author":"Baker","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.joca.2025.11.007_bib22","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/jama.2025.3471","article-title":"Metformin for knee osteoarthritis in patients with overweight or obesity: a randomized clinical trial","volume":"333","author":"Pan","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.joca.2025.11.007_bib23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ddr.21636","article-title":"A review of phenformin, metformin, and imeglimin","volume":"81","author":"Yendapally","year":"2020","journal-title":"Drug Dev. Res"},{"key":"10.1016\/j.joca.2025.11.007_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41598-023-27689-y","article-title":"Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes","volume":"13","author":"Hozumi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.joca.2025.11.007_bib25","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/antiox13111415","article-title":"Imeglimin halts liver damage by improving mitochondrial dysfunction in a nondiabetic male mouse model of metabolic dysfunction-associated steatohepatitis","volume":"13","author":"Kaji","year":"2024","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.joca.2025.11.007_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/cells13030284","article-title":"Imeglimin exhibits novel anti-inflammatory effects on high-glucose-stimulated mouse microglia through ULK1-mediated suppression of the TXNIP\u2013NLRP3 axis","volume":"13","author":"Kato","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.joca.2025.11.007_bib27","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/dom.16157","article-title":"Efficacy of imeglimin in patients with type 2 diabetes mellitus complicated by metabolic dysfunction-associated steatotic liver disease: A multicentre study","volume":"27","author":"Fukunaga","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.joca.2025.11.007_bib28","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.joca.2021.07.015","article-title":"TGF\u03b21 signaling protects chondrocytes against oxidative stress via FOXO1-autophagy axis","volume":"29","author":"Kurakazu","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2025.11.007_bib29","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100896R","article-title":"C10orf10\/DEPP activates mitochondrial autophagy and maintains chondrocyte viability in the pathogenesis of osteoarthritis","volume":"36","author":"Kuwahara","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.joca.2025.11.007_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.42421","article-title":"Promotion of knee cartilage degradation by I\u03baB kinase \u03b5 in the pathogenesis of osteoarthritis in human and murine models","volume":"75","author":"Uchida","year":"2023","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.joca.2025.11.007_bib31","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/ard-2023-224385","article-title":"Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice","volume":"82","author":"Collins","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2025.11.007_bib32","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/ard-2023-224945","article-title":"Primary osteoarthritis chondrocyte map of chromatin conformation reveals novel candidate effector genes","volume":"83","author":"Bittner","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2025.11.007_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.joca.2025.11.007_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan7967","article-title":"Mohawk is a transcription factor that promotes meniscus cell phenotype and tissue repair and reduces osteoarthritis severity","volume":"12","author":"Lee","year":"2020","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.joca.2025.11.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101249","article-title":"The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis","volume":"66","author":"Zheng","year":"2021","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.joca.2025.11.007_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-023-01330-w","article-title":"Osteoarthritis: pathogenic signaling pathways and therapeutic targets","volume":"8","author":"Yao","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.joca.2025.11.007_bib37","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/art.30333","article-title":"Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1\u03b2 and tumor necrosis factor \u03b1","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.joca.2025.11.007_bib38","article-title":"AMPK deficiency in chondrocytes accelerated the progression of instability-induced and ageing-associated osteoarthritis in adult mice","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.joca.2025.11.007_bib39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.21037\/atm.2019.06.77","article-title":"Estrogen prevents articular cartilage destruction in a mouse model of AMPK deficiency via ERK-mTOR pathway","volume":"7","author":"Ge","year":"2019","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.joca.2025.11.007_bib40","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/2211-5463.12989","article-title":"CCAL1 enhances osteoarthritis through the NF-\u03baB\/AMPK signaling pathway","volume":"10","author":"Zhu","year":"2020","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.joca.2025.11.007_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12979-019-0169-4","article-title":"Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype","volume":"16","author":"Del Rey","year":"2019","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.joca.2025.11.007_bib42","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/art.38791","article-title":"Peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 and FoxO3A mediate chondroprotection by AMP-activated protein kinase","volume":"66","author":"Zhao","year":"2014","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.joca.2025.11.007_bib43","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.joca.2005.03.004","article-title":"Osteoarthritis development in novel experimental mouse models induced by knee joint instability","volume":"13","author":"Kamekura","year":"2005","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2025.11.007_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169882","article-title":"The AMPK activator A769662 blocks voltage-gated sodium channels: discovery of a novel pharmacophore with potential utility for analgesic development","volume":"12","author":"Asiedu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.joca.2025.11.007_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-8069-8-5","article-title":"Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain","volume":"8","author":"Tillu","year":"2012","journal-title":"Mol. Pain."},{"key":"10.1016\/j.joca.2025.11.007_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12891-016-1286-2","article-title":"Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature","volume":"17","author":"Dell\u2019Isola","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.joca.2025.11.007_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.joca.2025.11.007_bib48","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15151","article-title":"Reduced lactic acidosis risk with imeglimin: comparison with metformin","volume":"10","author":"Theurey","year":"2022","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.joca.2025.11.007_bib49","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2337\/dc20-0763","article-title":"Efficacy and safety of imeglimin monotherapy versus placebo in Japanese patients with type 2 diabetes (TIMES 1): A double-blind, randomized, placebo-controlled, parallel-group, multicenter phase 3 trial","volume":"44","author":"Dubourg","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.joca.2025.11.007_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","article-title":"Metformin action: concentrations matter","volume":"21","author":"He","year":"2015","journal-title":"Cell Metab."}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106345842501235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106345842501235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:13:28Z","timestamp":1773850408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S106345842501235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S106345842501235X"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2025.11.007","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imeglimin, a novel antidiabetic agent related to metformin, attenuates knee osteoarthritis development and progression through AMPK activation and NF-\u03baB signaling inhibition","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2025.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.","name":"copyright","label":"Copyright"}]}}